Sartorius Stedim Biotech S.A. (FRA:56S1)

Sartorius Stedim Biotech Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,896	2,780	2,776	3,493	2,887	1,910
Revenue Growth (YoY)	5.44%	0.16%	-20.53%	20.98%	51.14%	32.59%
Cost of Revenue	1,604	1,573	1,542	1,675	1,334	906.76
Gross Profit	1,293	1,207	1,234	1,817	1,553	1,003
Selling, General & Admin	664.9	650.1	617.6	612.3	531.9	391.85
Research & Development	145.7	144.1	129.5	132.4	110.5	84.45
Other Operating Expenses	30.8	16.5	17.5	18.2	-9.6	23.89
Operating Expenses	841.4	810.7	764.6	762.9	632.8	500.19
Operating Income	451.4	396	469.4	1,054	920.2	503.14
Interest Expense	-141.8	-148	-115.4	-18.2	-10.2	-6.51
Interest & Investment Income	22.6	18.9	6.2	0.5	0.3	0.51
Earnings From Equity Investments	-8.6	-8.6	-	-	-	-
Currency Exchange Gain (Loss)	6.6	6.6	-13.3	-32.8	12.3	-14.66
Other Non Operating Income (Expenses)	-13	-12.9	-4.3	-4.6	-37.1	1.08
EBT Excluding Unusual Items	317.2	252	342.6	999.3	885.5	483.55
Merger & Restructuring Charges	-	-	-	-	-20.3	-4.3
Other Unusual Items	-32.8	-32.8	59.3	131.1	-218.5	-18.56
Pretax Income	284.4	219.2	401.9	1,130	646.7	460.69
Income Tax Expense	57.8	40.7	89.2	250.5	232.4	122.1
Earnings From Continuing Operations	226.6	178.5	312.7	879.9	414.3	338.6
Minority Interest in Earnings	-1.4	-3.4	-2.4	-3.8	0.1	-2.67
Net Income	225.2	175.1	310.3	876.1	414.4	335.93
Net Income to Common	225.2	175.1	310.3	876.1	414.4	335.93
Net Income Growth	32.39%	-43.57%	-64.58%	111.41%	23.36%	43.25%
Shares Outstanding (Basic)	97	97	92	92	92	92
Shares Outstanding (Diluted)	97	97	92	92	92	92
Shares Change (YoY)	3.36%	5.01%	-0.00%	-0.01%	-0.00%	0.00%
EPS (Basic)	2.31	1.81	3.37	9.51	4.50	3.64
EPS (Diluted)	2.31	1.81	3.37	9.51	4.50	3.64
EPS Growth	28.09%	-46.26%	-64.58%	111.45%	23.51%	43.31%
Free Cash Flow	496.5	475.3	272.8	181.7	377.9	257.69
Free Cash Flow Per Share	5.10	4.91	2.96	1.97	4.10	2.79
Dividend Per Share	0.690	0.690	0.690	1.440	1.260	0.680
Dividend Growth	-	-	-52.08%	14.29%	85.29%	100.00%
Gross Margin	44.64%	43.41%	44.46%	52.03%	53.79%	52.53%
Operating Margin	15.58%	14.24%	16.91%	30.19%	31.87%	26.34%
Profit Margin	7.78%	6.30%	11.18%	25.08%	14.35%	17.59%
Free Cash Flow Margin	17.14%	17.10%	9.83%	5.20%	13.09%	13.49%
EBITDA	695.1	629.3	657.7	1,197	1,031	577.32
EBITDA Margin	24.00%	22.64%	23.70%	34.27%	35.73%	30.23%
D&A For EBITDA	243.7	233.3	188.3	142.5	111.2	74.18
EBIT	451.4	396	469.4	1,054	920.2	503.14
EBIT Margin	15.58%	14.24%	16.91%	30.19%	31.87%	26.34%
Effective Tax Rate	20.32%	18.57%	22.20%	22.16%	35.94%	26.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.